Search
for
Sort by
Research 571–600 of 1000+
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- A Clinical Study on Cutaneous Manifestations of Obesity
- CLINICAL STUDY OF CUTANEOUS MANIFESTATION OF GERIATRIC AGE GROUP
- Subject Index
- Skin Disorders
- Dermatologic therapy: December 1987 to December 1988
- Safety and efficacy of microneedling with autologous platelet-rich plasma in chronic and stable alopecia areata
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- HAIR AND SYSTEMATIC DISEASE
- Hypertensive crisis associated with St. John’s Wort
- Aesthetic dermatology procedures in coronavirus days
- Mesococktails and mesoproducts in aesthetic dermatology
- Rituximab for Bone Lymphoma
- Hormones
- In vitro and in vivo investigations of the wound healing effect of crude Spirulina extract and C-phycocyanin
- Osteocalcin levels evaluation of freeze-dried homologus platelet-rich plasma in periodontal treatment
- Hair Disorders
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Türk kadınlarında görülen saç ve saçlı deri hastalıklarının değerlendirilmesi
- Chapter 6. Darwinian Health and Other Contradictions
- Neuroimaging of sleep and depression
- Low Level Laser and Light Therapy
- Blinding in Placebo-Controlled Trials
- A Rare Case of Antinuclear Antibody-Negative Systemic Lupus Erythematosus Presenting With Generalized Lymphadenopathy as the Initial Manifestation
- Alopecia and grey hair are associated with COVID‐19 Severity
- Balint’s syndrome—missed or mistaken?
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders